chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Peripheral swelling, Rash, Swelling, Vaccination site pain
Clinical narrative: After 2nd Shot 1-5 days swelling and rash; After 2nd Shot 1-5 days swelling and rash.; Pain in arm at injection side; Day 3-4 Throbbing leg - felt arteryflutter; Day 3-4 Throbbing leg - felt artery flutter; 1-12 days recurring headache; 3-18 days pain in shoulder and armpitnear injection site; 3-18 days pain in shoulder and armpitnear injection site; Day 12-18 swelling in hand; Day 2-18 - extreme fatigue; Day 2-18 - higher blood pressure; Day 4-18  Nausea and forgetfulness; Day 4-18  Nausea and forgetfulness; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0152) via an unspecified route of administration in the right arm on 06Apr2021 at 11:30 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included cancer, had lower platelets during cancer treatment and allergic to latex. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN) for unknown indications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0205) via an unspecified route of administration in the left arm on 16Mar2021 at 11:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. After 2nd Shot on an unknown date in Apr2021, on days 1-5, the patient experienced swelling, rash, pain in arm at injection side. On days 3-4, the patient had throbbing leg-felt artery flutter. On days 1-12, the patient had recurring headache. On days 3-18, the patient experienced pain in shoulder and armpit near injection site. On days 12-18, the patient had swelling in hand and on days 2-18 felt extreme fatigue. On days 2-18, the patient had higher blood pressure and on days 4-18 nausea and forgetfulness. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swelling and rash, pain in arm at injection side, throbbing leg, felt artery flutter, recurring headache, pain in shoulder and armpit near injection site, extreme fatigue, higher blood pressure, nausea, forgetfulness and swelling in hand were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia
Clinical narrative: My left leg feels numb after I got the first dose Pfizer covid-19 vaccine. It's been going on for over a week..My left leg still feels numb and it's not getting any better; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Apr2021 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included bell's palsy at 2018. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Apr2021, the patients left leg felt numb after she got the first dose Pfizer COVID-19 vaccine. It had been going on for over a week. Her left leg still felt numb and it was not getting any better. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event left leg felt numb after the patient got the first dose Pfizer COVID-19 vaccine; it had been going on for over a week; her left leg still felt numb and it was not getting any better was not resolved at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Burning sensation, Chills, Electric shock sensation, Feeling abnormal, Gait disturbance
Clinical narrative: In the night of the vaccine I started to get tingling feeling at times in my arms, hands, legs, feet, side, chest and head.  Then at times this electric shock feeling in different areas.  Then very he; Very heavy in my legs; Very heavy and weak in my legs; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW40151) via an unspecified route of administration in the arm left on 14Apr2021 at 15:00(at the age of 43-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had known allergies to sulfa drugs. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included sertraline hydrochloride (ZOLOFT), omeprazole (MANUFACTURER UNKNOWN) and loratadine (MANUFACTURER UNKNOWN) all from unknown date for unknown indication and unknown if ongoing. On 14Apr2021 at 20:00, the patient experienced in the night of the vaccine, started to get tingling feeling at times in arms, hands, legs, feet, side, chest and head. Then at times this electric shock feeling in different areas. Then very heavy and weak in the legs. Doing better but still had tingling in the right leg and foot and never stops. Still electric shock feeling at times. doctor thought maybe a nerve response to the vaccine. Been over a week now and hadn't stop. This is a very uneasy feeling and looking for any info. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events, in the night of the vaccine, it started to get tingling feeling at times in arms, hands, legs, feet, side, chest and head. Then at times this electric shock feeling in different areas. Then very heavy and weak in the legs. Doing better but still had tingling in the right leg and foot and never stops. Still electric shock feeling at times. doctor thought maybe a nerve response to the vaccine. Been over a week now and hadn't stop. This is a very uneasy feeling and looking for any info was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Muscular weakness, Pain in extremity, Paraesthesia, Sleep disorder
Clinical narrative: In the night of the vaccine I started to get tingling feeling at times in my arms, hands, legs, feet, side, chest and head.  Then at times this electric shock feeling in different areas.  Then very he; Very heavy in my legs; Very heavy and weak in my legs; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW40151) via an unspecified route of administration in the arm left on 14Apr2021 at 15:00(at the age of 43-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had known allergies to sulfa drugs. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included sertraline hydrochloride (ZOLOFT), omeprazole (MANUFACTURER UNKNOWN) and loratadine (MANUFACTURER UNKNOWN) all from unknown date for unknown indication and unknown if ongoing. On 14Apr2021 at 20:00, the patient experienced in the night of the vaccine, started to get tingling feeling at times in arms, hands, legs, feet, side, chest and head. Then at times this electric shock feeling in different areas. Then very heavy and weak in the legs. Doing better but still had tingling in the right leg and foot and never stops. Still electric shock feeling at times. doctor thought maybe a nerve response to the vaccine. Been over a week now and hadn't stop. This is a very uneasy feeling and looking for any info. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events, in the night of the vaccine, it started to get tingling feeling at times in arms, hands, legs, feet, side, chest and head. Then at times this electric shock feeling in different areas. Then very heavy and weak in the legs. Doing better but still had tingling in the right leg and foot and never stops. Still electric shock feeling at times. doctor thought maybe a nerve response to the vaccine. Been over a week now and hadn't stop. This is a very uneasy feeling and looking for any info was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Limb discomfort, Muscular weakness, Paraesthesia
Clinical narrative: In the night of the vaccine I started to get tingling feeling at times in my arms, hands, legs, feet, side, chest and head.  Then at times this electric shock feeling in different areas.  Then very he; Very heavy in my legs; Very heavy and weak in my legs; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW40151) via an unspecified route of administration in the arm left on 14Apr2021 at 15:00(at the age of 43-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had known allergies to sulfa drugs. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included sertraline hydrochloride (ZOLOFT), omeprazole (MANUFACTURER UNKNOWN) and loratadine (MANUFACTURER UNKNOWN) all from unknown date for unknown indication and unknown if ongoing. On 14Apr2021 at 20:00, the patient experienced in the night of the vaccine, started to get tingling feeling at times in arms, hands, legs, feet, side, chest and head. Then at times this electric shock feeling in different areas. Then very heavy and weak in the legs. Doing better but still had tingling in the right leg and foot and never stops. Still electric shock feeling at times. doctor thought maybe a nerve response to the vaccine. Been over a week now and hadn't stop. This is a very uneasy feeling and looking for any info. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events, in the night of the vaccine, it started to get tingling feeling at times in arms, hands, legs, feet, side, chest and head. Then at times this electric shock feeling in different areas. Then very heavy and weak in the legs. Doing better but still had tingling in the right leg and foot and never stops. Still electric shock feeling at times. doctor thought maybe a nerve response to the vaccine. Been over a week now and hadn't stop. This is a very uneasy feeling and looking for any info was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain upper, Diarrhoea, Dizziness, Fatigue, Heart rate
Clinical narrative: Nausea; Fatigue; Profuse watery diarrhea; Buzzing in back of head; Dizziness; Weakness; Blurry vision in right eye only; Some numbness of tongue; Tinnitus; Stabbing pain in stomach; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 21Apr2021 (at the age of 61-years-old) at 09:30 as a single dose for COVID-19 immunisation. Medical history included post-traumatic stress disorder (chronic complex PTSD), traumatic brain injury, hashimotos thyroiditis, sulfonamide allergy and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levothyroxine sodium (SYNTHROID), liothyronine sodium (CYTOMEL), vitamin d nos (MANUFACTURER UNKNOWN) and probiotics nos (MANUFACTURER UNKNOWN) all from unknown dates and unknown if ongoing for unknown indications. The patient previously took levofloxacin(LEVAQUIN) and experienced drug allergy. On 21Apr2021 at 14:00 the patient experienced some numbness of tongue, dizziness, nausea, weakness, fatigue, tinnitus, stabbing pain in stomach, profuse watery diarrhea, buzzing in back of head and blurry vision in right eye only. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events some numbness of tongue, dizziness, nausea, weakness, fatigue, tinnitus, stabbing pain in stomach, profuse watery diarrhea, buzzing in back of head and blurry vision in right eye only was recovered with sequelae on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia oral, Nausea, Tinnitus, Vision blurred
Clinical narrative: Nausea; Fatigue; Profuse watery diarrhea; Buzzing in back of head; Dizziness; Weakness; Blurry vision in right eye only; Some numbness of tongue; Tinnitus; Stabbing pain in stomach; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 21Apr2021 (at the age of 61-years-old) at 09:30 as a single dose for COVID-19 immunisation. Medical history included post-traumatic stress disorder (chronic complex PTSD), traumatic brain injury, hashimotos thyroiditis, sulfonamide allergy and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levothyroxine sodium (SYNTHROID), liothyronine sodium (CYTOMEL), vitamin d nos (MANUFACTURER UNKNOWN) and probiotics nos (MANUFACTURER UNKNOWN) all from unknown dates and unknown if ongoing for unknown indications. The patient previously took levofloxacin(LEVAQUIN) and experienced drug allergy. On 21Apr2021 at 14:00 the patient experienced some numbness of tongue, dizziness, nausea, weakness, fatigue, tinnitus, stabbing pain in stomach, profuse watery diarrhea, buzzing in back of head and blurry vision in right eye only. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events some numbness of tongue, dizziness, nausea, weakness, fatigue, tinnitus, stabbing pain in stomach, profuse watery diarrhea, buzzing in back of head and blurry vision in right eye only was recovered with sequelae on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain upper, Asthenia, Diarrhoea, Dizziness, Fatigue
Clinical narrative: Nausea; Fatigue; Profuse watery diarrhea; Buzzing in back of head; Dizziness; Weakness; Blurry vision in right eye only; Some numbness of tongue; Tinnitus; Stabbing pain in stomach; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 21Apr2021 (at the age of 61-years-old) at 09:30 as a single dose for COVID-19 immunisation. Medical history included post-traumatic stress disorder (chronic complex PTSD), traumatic brain injury, hashimotos thyroiditis, sulfonamide allergy and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levothyroxine sodium (SYNTHROID), liothyronine sodium (CYTOMEL), vitamin d nos (MANUFACTURER UNKNOWN) and probiotics nos (MANUFACTURER UNKNOWN) all from unknown dates and unknown if ongoing for unknown indications. The patient previously took levofloxacin(LEVAQUIN) and experienced drug allergy. On 21Apr2021 at 14:00 the patient experienced some numbness of tongue, dizziness, nausea, weakness, fatigue, tinnitus, stabbing pain in stomach, profuse watery diarrhea, buzzing in back of head and blurry vision in right eye only. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events some numbness of tongue, dizziness, nausea, weakness, fatigue, tinnitus, stabbing pain in stomach, profuse watery diarrhea, buzzing in back of head and blurry vision in right eye only was recovered with sequelae on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia oral, Nausea, Paraesthesia, Tinnitus, Vision blurred
Clinical narrative: Nausea; Fatigue; Profuse watery diarrhea; Buzzing in back of head; Dizziness; Weakness; Blurry vision in right eye only; Some numbness of tongue; Tinnitus; Stabbing pain in stomach; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 21Apr2021 (at the age of 61-years-old) at 09:30 as a single dose for COVID-19 immunisation. Medical history included post-traumatic stress disorder (chronic complex PTSD), traumatic brain injury, hashimotos thyroiditis, sulfonamide allergy and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levothyroxine sodium (SYNTHROID), liothyronine sodium (CYTOMEL), vitamin d nos (MANUFACTURER UNKNOWN) and probiotics nos (MANUFACTURER UNKNOWN) all from unknown dates and unknown if ongoing for unknown indications. The patient previously took levofloxacin(LEVAQUIN) and experienced drug allergy. On 21Apr2021 at 14:00 the patient experienced some numbness of tongue, dizziness, nausea, weakness, fatigue, tinnitus, stabbing pain in stomach, profuse watery diarrhea, buzzing in back of head and blurry vision in right eye only. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events some numbness of tongue, dizziness, nausea, weakness, fatigue, tinnitus, stabbing pain in stomach, profuse watery diarrhea, buzzing in back of head and blurry vision in right eye only was recovered with sequelae on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Rash, Urticaria
Clinical narrative: Rash over entire that started 4 days after second dose.; It itches like crazy and comes and goes in waves.; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 16255) via an unspecified route of administration in the left arm on 22Apr2021 at 10:45 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 01Apr2021 at 10:45 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. On 26Apr2021 at 16:30, the patient experienced rash over entire that started 4 days after second dose. It itched like crazy and comes and goes in waves. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result and included treatment with prescription cream. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events rash and itching was not recovered at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Rash, Rash pruritic
Clinical narrative: Rash over entire that started 4 days after second dose.; It itches like crazy and comes and goes in waves.; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 16255) via an unspecified route of administration in the left arm on 22Apr2021 at 10:45 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 01Apr2021 at 10:45 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. On 26Apr2021 at 16:30, the patient experienced rash over entire that started 4 days after second dose. It itched like crazy and comes and goes in waves. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result and included treatment with prescription cream. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events rash and itching was not recovered at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Discomfort, Lymph node pain, Lymphadenopathy
Clinical narrative: Very sore lymph nodes; Discomfort left armpit area extending under and toward breast area. Also sore right side, more severe left side. Lasted for about 1.5 weeks.; Discomfort even when not moving, discomfort when arms at sides.; This is a spontaneous report from a contactable healthcare professional, the patient. A 26-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07Apr2021 at 11:00 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history included occasional migraine and headaches. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included loratadine (MANUFACTURER UNKNOWN) for unknown indication from unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17Mar2021 at 11:15 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. On 09Apr2021 at 08:00, the patient experienced very sore lymph nodes/discomfort left armpit area extending under and toward breast area. Also, sore right side, more severe left side which lasted for about 1.5 weeks. The patient had discomfort even when not moving and discomfort when arms at sides. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events very sore lymph nodes/discomfort left armpit area extending under and toward breast area, also sore right side, more severe left side, discomfort even when not moving, discomfort when arms at sides were resolved on an unknown date in Apr2021.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Axillary pain, Limb discomfort, Lymph node pain
Clinical narrative: Very sore lymph nodes; Discomfort left armpit area extending under and toward breast area. Also sore right side, more severe left side. Lasted for about 1.5 weeks.; Discomfort even when not moving, discomfort when arms at sides.; This is a spontaneous report from a contactable healthcare professional, the patient. A 26-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07Apr2021 at 11:00 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history included occasional migraine and headaches. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included loratadine (MANUFACTURER UNKNOWN) for unknown indication from unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17Mar2021 at 11:15 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. On 09Apr2021 at 08:00, the patient experienced very sore lymph nodes/discomfort left armpit area extending under and toward breast area. Also, sore right side, more severe left side which lasted for about 1.5 weeks. The patient had discomfort even when not moving and discomfort when arms at sides. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events very sore lymph nodes/discomfort left armpit area extending under and toward breast area, also sore right side, more severe left side, discomfort even when not moving, discomfort when arms at sides were resolved on an unknown date in Apr2021.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Insomnia, Myalgia, Pyrexia
Clinical narrative: Fever; Chills; Muscle aches; Fatigue; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 27Apr2021 at 10:45 at the age of 60-years-old as a single dose for COVID-19 immunisation. The patient did not have any medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included unspecified Multivitamin and VITAMIN C, taken for unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the left arm on 22Mar2021 at 09:45 at the age of 60-years-old as a single dose for COVID-19 immunisation. The patient previously took CODEINE for unknown indication and experienced drug allergy. On 28Apr2021 at 21:00, the patient experienced fever, chills, muscle aches, fatigue, and nausea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events was fever, chills, muscle aches, fatigue, and nausea was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Fatigue, Myalgia, Nausea, Pyrexia
Clinical narrative: Fever; Chills; Muscle aches; Fatigue; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 27Apr2021 at 10:45 at the age of 60-years-old as a single dose for COVID-19 immunisation. The patient did not have any medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included unspecified Multivitamin and VITAMIN C, taken for unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the left arm on 22Mar2021 at 09:45 at the age of 60-years-old as a single dose for COVID-19 immunisation. The patient previously took CODEINE for unknown indication and experienced drug allergy. On 28Apr2021 at 21:00, the patient experienced fever, chills, muscle aches, fatigue, and nausea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events was fever, chills, muscle aches, fatigue, and nausea was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 20.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood magnesium normal, Blood phosphorus normal, Computerised tomogram head normal, Full blood count normal, Headache
Clinical narrative: Severe headaches lasting 6 days from 4/15/21-4/21/21, started at same time of evening ~5pm lasting many hours, discussed as cluster headaches or migraines by Student Health but concerned of Pfizer adverse effects and sent to ER for further ruling out; Negatively impacted study and work,physical and emotional tolls from not being able to sleep or complete assignements; Negatively impacted study and work,physical and emotional tolls from not being able to sleep or complete assignements; This is a spontaneous report from a contactable consumer, the patient. A 20-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the arm left on 28Mar2021 at 05:00(at the age of 20-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergies to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications topical retinol cream (MANUFACTURER UNKNOWN). The patient previously took amoxicillin (MANUFACTURER UNKNOWN) and experienced drug allergy. On 09Apr2021, the patient underwent nasal Swab and the result was Negative. On 15Apr2021 the patient experienced Severe headaches lasting 6 days from 4/15/21-4/21/21, started at same time of evening 5pm lasting many hours, discussed as cluster headaches or migraines by Student Health but concerned of Pfizer adverse effects and sent to ER for further ruling out of delayed adverse from vaccine. Negatively impacted study and work, physical and emotional tolls from not being able to sleep or complete assignements. Acute headache onset was after the first shot of Pfizer covid vaccine. Sent to emergency room (4/21) by Student Health. Doctor impression acute non-intractable headache. The events resulted in emergency room/department visit or urgent care. Therapeutic measures were taken as a result of the events which included treatment with are acetaminophen (TYLENOL), diphenhydramine (BENADRYL) and metoclopramide (REGLAN IV). On 23Apr2021, the patient underwent Nasal Swab and the result was Negative. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the event Severe headaches lasting 6 days from 4/15/21-4/21/21, started at same time of evening 5pm lasting many hours, discussed as cluster headaches or migraines by Student Health but concerned of Pfizer adverse effects and sent to ER for further ruling out of delayed adverse from vaccine. Negatively impacted study and work, physical and emotional tolls from not being able to sleep or complete assignements was recovering at this time of report.   No follow-up attempts are possible. No further information is expected.
Age: 20.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Impaired work ability, Laboratory test normal, Loss of personal independence in daily activities, Monocyte percentage increased
Clinical narrative: Severe headaches lasting 6 days from 4/15/21-4/21/21, started at same time of evening ~5pm lasting many hours, discussed as cluster headaches or migraines by Student Health but concerned of Pfizer adverse effects and sent to ER for further ruling out; Negatively impacted study and work,physical and emotional tolls from not being able to sleep or complete assignements; Negatively impacted study and work,physical and emotional tolls from not being able to sleep or complete assignements; This is a spontaneous report from a contactable consumer, the patient. A 20-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the arm left on 28Mar2021 at 05:00(at the age of 20-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergies to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications topical retinol cream (MANUFACTURER UNKNOWN). The patient previously took amoxicillin (MANUFACTURER UNKNOWN) and experienced drug allergy. On 09Apr2021, the patient underwent nasal Swab and the result was Negative. On 15Apr2021 the patient experienced Severe headaches lasting 6 days from 4/15/21-4/21/21, started at same time of evening 5pm lasting many hours, discussed as cluster headaches or migraines by Student Health but concerned of Pfizer adverse effects and sent to ER for further ruling out of delayed adverse from vaccine. Negatively impacted study and work, physical and emotional tolls from not being able to sleep or complete assignements. Acute headache onset was after the first shot of Pfizer covid vaccine. Sent to emergency room (4/21) by Student Health. Doctor impression acute non-intractable headache. The events resulted in emergency room/department visit or urgent care. Therapeutic measures were taken as a result of the events which included treatment with are acetaminophen (TYLENOL), diphenhydramine (BENADRYL) and metoclopramide (REGLAN IV). On 23Apr2021, the patient underwent Nasal Swab and the result was Negative. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the event Severe headaches lasting 6 days from 4/15/21-4/21/21, started at same time of evening 5pm lasting many hours, discussed as cluster headaches or migraines by Student Health but concerned of Pfizer adverse effects and sent to ER for further ruling out of delayed adverse from vaccine. Negatively impacted study and work, physical and emotional tolls from not being able to sleep or complete assignements was recovering at this time of report.   No follow-up attempts are possible. No further information is expected.
Age: 20.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Headache, Insomnia, Loss of personal independence in daily activities, SARS-CoV-2 test
Clinical narrative: Severe headaches lasting 6 days from 4/15/21-4/21/21, started at same time of evening ~5pm lasting many hours, discussed as cluster headaches or migraines by Student Health but concerned of Pfizer adverse effects and sent to ER for further ruling out; Negatively impacted study and work,physical and emotional tolls from not being able to sleep or complete assignements; Negatively impacted study and work,physical and emotional tolls from not being able to sleep or complete assignements; This is a spontaneous report from a contactable consumer, the patient. A 20-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the arm left on 28Mar2021 at 05:00(at the age of 20-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergies to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications topical retinol cream (MANUFACTURER UNKNOWN). The patient previously took amoxicillin (MANUFACTURER UNKNOWN) and experienced drug allergy. On 09Apr2021, the patient underwent nasal Swab and the result was Negative. On 15Apr2021 the patient experienced Severe headaches lasting 6 days from 4/15/21-4/21/21, started at same time of evening 5pm lasting many hours, discussed as cluster headaches or migraines by Student Health but concerned of Pfizer adverse effects and sent to ER for further ruling out of delayed adverse from vaccine. Negatively impacted study and work, physical and emotional tolls from not being able to sleep or complete assignements. Acute headache onset was after the first shot of Pfizer covid vaccine. Sent to emergency room (4/21) by Student Health. Doctor impression acute non-intractable headache. The events resulted in emergency room/department visit or urgent care. Therapeutic measures were taken as a result of the events which included treatment with are acetaminophen (TYLENOL), diphenhydramine (BENADRYL) and metoclopramide (REGLAN IV). On 23Apr2021, the patient underwent Nasal Swab and the result was Negative. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the event Severe headaches lasting 6 days from 4/15/21-4/21/21, started at same time of evening 5pm lasting many hours, discussed as cluster headaches or migraines by Student Health but concerned of Pfizer adverse effects and sent to ER for further ruling out of delayed adverse from vaccine. Negatively impacted study and work, physical and emotional tolls from not being able to sleep or complete assignements was recovering at this time of report.   No follow-up attempts are possible. No further information is expected.
Age: 44.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Rash, Rash pruritic
Clinical narrative: Rash on right arm inside elbow; Rash on right arm inside elbow and it's sometimes itchy; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the arm left on 15Apr2021 at 13:45 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. The medical history included diabetes insipidus. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The concomitant medications included desmopressin acetate (DDAVP) and multivitamins (unspecified), all from unknown dates for unknown indications and unknown if ongoing. On 22Apr2021, the patient experienced rash on right arm inside elbow and it was sometimes itchy. The patient did not receive any treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events rash on right arm inside elbow and was itchy were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Axillary pain, Back pain, Breast pain, Breast swelling, Chest pain
Clinical narrative: Left breast twice the size of right breast; Left breast twice the size of right breast with pain that runs from my left side of neck down through breast/armpit area and left back area.; Left breast twice the size of right breast with pain that runs from my left side of neck down through breast/armpit area and left back area.; Left breast twice the size of right breast with pain that runs from my left side of neck down through breast/armpit area and left back area.; Left breast twice the size of right breast with pain that runs from my left side of neck down through breast/armpit area and left back area.; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: GW0169) via an unspecified route of administration in the left arm on 27Apr2021 at 21:30 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included possible early COPD, asthma, penicillin allergy, allergy to sulfa (sulfonamide allergy) and allergy to drinking alcohol (alcohol allergy). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ketorolac (MANUFACTURER UNKNOWN), fluticasone furoate (ARNUITY ELLIPTA), progesterone (MANUFACTURER UNKNOWN) and estradiol (ESTROGEN); all for unknown indication from unknown date and unknown if ongoing. The patient previously received ocrilate (DERMABOND) for unknown indication on an unknown date and experienced drug allergy.  On 28Apr2021 at 12:00, the patient's left breast increased twice the size of right breast with pain that runs from left side of neck down through breast / armpit area and left back area. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events left breast twice the size of right breast with pain that runs from left side of neck down through breast / armpit area and left back area were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Neck pain
Clinical narrative: Left breast twice the size of right breast; Left breast twice the size of right breast with pain that runs from my left side of neck down through breast/armpit area and left back area.; Left breast twice the size of right breast with pain that runs from my left side of neck down through breast/armpit area and left back area.; Left breast twice the size of right breast with pain that runs from my left side of neck down through breast/armpit area and left back area.; Left breast twice the size of right breast with pain that runs from my left side of neck down through breast/armpit area and left back area.; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: GW0169) via an unspecified route of administration in the left arm on 27Apr2021 at 21:30 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included possible early COPD, asthma, penicillin allergy, allergy to sulfa (sulfonamide allergy) and allergy to drinking alcohol (alcohol allergy). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ketorolac (MANUFACTURER UNKNOWN), fluticasone furoate (ARNUITY ELLIPTA), progesterone (MANUFACTURER UNKNOWN) and estradiol (ESTROGEN); all for unknown indication from unknown date and unknown if ongoing. The patient previously received ocrilate (DERMABOND) for unknown indication on an unknown date and experienced drug allergy.  On 28Apr2021 at 12:00, the patient's left breast increased twice the size of right breast with pain that runs from left side of neck down through breast / armpit area and left back area. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events left breast twice the size of right breast with pain that runs from left side of neck down through breast / armpit area and left back area were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.